Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Guangdong Provincial People's Hospital
Zhujiang Hospital
Mayo Clinic
Fudan University
Peking Union Medical College Hospital
Başakşehir Çam & Sakura City Hospital
Tongji Hospital
Assiut University
Latin American Cooperative Oncology Group
Assiut University
Centre Leon Berard
Peking Union Medical College Hospital
Centre hospitalier de l'Université de Montréal (CHUM)
The First Affiliated Hospital of Xinxiang Medical College
Peking Union Medical College Hospital
Royal Marsden NHS Foundation Trust
Chinese PLA General Hospital
Gruppo Italiano Malattie EMatologiche dell'Adulto
First Affiliated Hospital Xi'an Jiaotong University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Peking Union Medical College Hospital
Xiangya Hospital of Central South University